| Literature DB >> 34337553 |
C Lee Cohen1,2, Katherine H Walker1,2, Mina Hsiang1, Paul D Sonenthal1,2,3, Elisabeth D Riviello2,4, Shada A Rouhani2,3,5, Michael S Lipnick6, Louis T Merriam1, Edy Y Kim1,2.
Abstract
The speed and scale of new information during the COVID-19 pandemic required a new approach toward developing best practices and evidence-based clinical guidance. To address this need, we produced COVIDProtocols.org, a collaborative, evidence-based, digital platform for the development and dissemination of COVID-19 clinical guidelines that has been used by over 500,000 people from 196 countries. We use a Collaborative Writing Application (CWA) to facilitate an expedited expert review process and a web platform that deploys content directly from the CWA to minimize any delays. Over 200 contributors have volunteered to create open creative-commons content that spans over 30 specialties and medical disciplines. Multiple local and national governments, hospitals, and clinics have used the site as a key resource for their own clinical guideline development. COVIDprotocols.org represents a model for efficiently launching open-access clinical guidelines during crisis situations to share expertise and combat misinformation.Entities:
Mesh:
Year: 2021 PMID: 34337553 PMCID: PMC8313756 DOI: 10.1016/j.xcrm.2021.100375
Source DB: PubMed Journal: Cell Rep Med ISSN: 2666-3791
Figure 1COVIDprotocols.org models a continuously updated collaborative clinical guideline process
(A) Collaborative guidelines process; CWA, collaborative writing application (i.e., Google Docs).
(B) COVIDprotocols.org homepage and key features.